510(k) K933997
K933997 is an FDA 510(k) premarket notification submitted by Alexon Biomedical, Inc. for the device "PROSPECT ENTAMOEBA HISTOLYTICA MICROPLATE ASSAY". The FDA issued a decision of Substantially Equivalent on Nov 22, 1993. The device falls under product code GMD (Antisera, Latex Agglutination, Cryptococcus Neoformans), a Class II device regulated under 21 CFR 866.3165. Alexon Biomedical, Inc. has 4 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 22, 1993
- Date Received
- Aug 17, 1993
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antisera, Latex Agglutination, Cryptococcus Neoformans
- Device Class
- Class II
- Regulation Number
- 866.3165
- Review Panel
- MI
- Submission Type
- 510(k) Exempt
Need the full FDA record for Alexon Biomedical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.